HUP9900750A2 - Gén kifejezésére szolgáló promóterek - Google Patents

Gén kifejezésére szolgáló promóterek

Info

Publication number
HUP9900750A2
HUP9900750A2 HU9900750A HUP9900750A HUP9900750A2 HU P9900750 A2 HUP9900750 A2 HU P9900750A2 HU 9900750 A HU9900750 A HU 9900750A HU P9900750 A HUP9900750 A HU P9900750A HU P9900750 A2 HUP9900750 A2 HU P9900750A2
Authority
HU
Hungary
Prior art keywords
protein
dna structures
promoters
gene expression
production
Prior art date
Application number
HU9900750A
Other languages
English (en)
Inventor
Peter A. Lagosky
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of HUP9900750A2 publication Critical patent/HUP9900750A2/hu
Publication of HUP9900750A3 publication Critical patent/HUP9900750A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • C12N15/72Expression systems using regulatory sequences derived from the lac-operon
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A találmány őlyan rekőmbináns DNS-szerkezetekre vőnatkőzik, melyekfehérjék bakteriális gazdákban történő termelésére szőlgálnak. Arekőmbináns DNS-szerkezetek egy fehérjét kódőló régiót és egy ehhezműködőképesen kapcsőlt, az említett fehérjének a gazdasejtben történőexpresszióját irányító prőmőtert tartalmazó szabályőzó régióttartalmaznak. A prőmőter a 5'-TTGACAACATAAAAAACTTTGTGTTATACT-3' vagy5'-TTGACACTTTATGCTTCCGGCTCGTATACT-3' DNS-szekvenciát tartalmazza. Atalálmány tővábbá a fenti rekőmbináns DNS-szerkezeteket tartalmazóvektőrőkra, ezekkel transzfőrmált gazdasejtekre és fehérjékelőállítási eljárásra is vőnatkőzik. ŕ
HU9900750A 1995-05-19 1996-05-16 Promoters for gene expression HUP9900750A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/445,133 US5629205A (en) 1995-05-19 1995-05-19 Promoters for gene expression

Publications (2)

Publication Number Publication Date
HUP9900750A2 true HUP9900750A2 (hu) 1999-06-28
HUP9900750A3 HUP9900750A3 (en) 1999-11-29

Family

ID=23767732

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900750A HUP9900750A3 (en) 1995-05-19 1996-05-16 Promoters for gene expression

Country Status (25)

Country Link
US (1) US5629205A (hu)
EP (1) EP0828844B1 (hu)
JP (2) JP3828576B2 (hu)
KR (1) KR19990014906A (hu)
CN (1) CN1131313C (hu)
AT (1) ATE248923T1 (hu)
AU (1) AU698656B2 (hu)
BR (1) BR9609102A (hu)
CA (1) CA2221587C (hu)
CZ (1) CZ357997A3 (hu)
DE (1) DE69629808T2 (hu)
DK (1) DK0828844T3 (hu)
EE (1) EE9700355A (hu)
ES (1) ES2202436T3 (hu)
HK (1) HK1004148A1 (hu)
HU (1) HUP9900750A3 (hu)
IS (1) IS4609A (hu)
MX (1) MX9708689A (hu)
NO (1) NO325879B1 (hu)
NZ (1) NZ306536A (hu)
PL (1) PL324226A1 (hu)
PT (1) PT828844E (hu)
SK (1) SK154997A3 (hu)
TR (1) TR199701394T1 (hu)
WO (1) WO1996036721A1 (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194168B1 (en) 1997-09-30 2001-02-27 Human Genome Sciences, Inc. Expression control sequences
EP1572720A4 (en) * 2002-05-24 2008-12-24 Nps Allelix Corp PROCESS FOR THE ENZYMATIC PRODUCTION OF GLP-2 (1-34) AND GLP-2 (1-33) PEPTIDES
US20050119183A1 (en) * 2003-11-12 2005-06-02 Nps Allelix Corp. Method for treating bone loss using parathyroid hormone
DK1704234T3 (da) * 2003-11-21 2012-05-07 Nps Pharma Inc Fremstilling af glucagon-lignende peptid 2 og analoger
WO2005058946A2 (en) * 2003-12-12 2005-06-30 Zymogenetics, Inc. Methods for enhancing expression of recombinant proteins
MA45489A (fr) 2015-10-22 2018-08-29 Juno Therapeutics Gmbh Procédés de culture de cellules, kits et appareil associés
KR102606210B1 (ko) 2017-04-27 2023-11-24 주노 테라퓨틱스 게엠베하 올리고머 입자 시약 및 이의 사용 방법
CN108060168B (zh) * 2017-12-29 2021-06-29 苏州金唯智生物科技有限公司 一种改进的启动子及其组成的t载体和应用
CN108165551B (zh) * 2017-12-30 2021-06-29 苏州金唯智生物科技有限公司 一种改进的启动子及其组成的t载体和应用
CN108118059B (zh) * 2017-12-30 2021-03-19 苏州金唯智生物科技有限公司 一种改进的启动子及其组成的载体和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8517071D0 (en) * 1985-07-05 1985-08-14 Hoffmann La Roche Gram-positive expression control sequence
ATE123526T1 (de) * 1987-08-17 1995-06-15 Hoffmann La Roche Hochreprimierbare expressionskontrollsequenzen.
US5223407A (en) * 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
US5171670A (en) * 1989-05-12 1992-12-15 The General Hospital Corporation Recombinant dna method for production of parathyroid hormone
JPH05509001A (ja) * 1990-08-28 1993-12-16 イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー 有効な分泌用ベクター類の迅速選択方法

Also Published As

Publication number Publication date
CA2221587C (en) 2008-07-08
KR19990014906A (ko) 1999-02-25
NO325879B1 (no) 2008-08-11
BR9609102A (pt) 1999-05-11
CN1190993A (zh) 1998-08-19
IS4609A (is) 1997-11-07
CA2221587A1 (en) 1996-11-21
HK1004148A1 (en) 1998-11-20
AU5511696A (en) 1996-11-29
JP3828576B2 (ja) 2006-10-04
EE9700355A (et) 1998-06-15
HUP9900750A3 (en) 1999-11-29
US5629205A (en) 1997-05-13
AU698656B2 (en) 1998-11-05
ES2202436T3 (es) 2004-04-01
PL324226A1 (en) 1998-05-11
DE69629808T2 (de) 2004-07-15
DK0828844T3 (da) 2004-01-05
ATE248923T1 (de) 2003-09-15
JP3837154B2 (ja) 2006-10-25
JP2006187295A (ja) 2006-07-20
TR199701394T1 (xx) 1998-02-21
NO975286D0 (no) 1997-11-18
EP0828844A1 (en) 1998-03-18
EP0828844B1 (en) 2003-09-03
SK154997A3 (en) 1998-05-06
NZ306536A (en) 1999-10-28
DE69629808D1 (de) 2003-10-09
NO975286L (no) 1997-11-18
CZ357997A3 (cs) 1998-04-15
PT828844E (pt) 2004-01-30
MX9708689A (es) 1998-02-28
JPH11509083A (ja) 1999-08-17
CN1131313C (zh) 2003-12-17
WO1996036721A1 (en) 1996-11-21

Similar Documents

Publication Publication Date Title
DE69636866D1 (en) Reverse "two-hybrid"-systeme
ATE184052T1 (de) Gdf-1 und uog1 proteine
DE69534733D1 (de) NEUARTIGE AUF p53 ANSPRECHENDE GENE
EP1757689A3 (en) Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
EP1005540A4 (en) IKK-BETA PROTEINS, NUCLEIC ACIDS AND METHODS
BR9610511B1 (pt) construções de dna, úteis em terapia genética, compreendendo ao menos uma sequência nucléica de interesse e composição farmacêutica.
PT941352E (pt) Milhoramentos em, ou relacionados com, o conteudo de amido em plantas.
KR950032279A (ko) 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna)
WO1997014809A3 (en) Novel expression vectors and methods of use
DE69632827D1 (de) Materialen und methoden im zusammenhang mit bindung und präsentation von substanzen auf zelloberflächen
KR970707153A (ko) 카텝신 02 프로테아제(cathepsin 02 protease)
HUP9900750A2 (hu) Gén kifejezésére szolgáló promóterek
ATE277171T1 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
FR2679253B1 (fr) Proteines de resistance a la cycloheximide. utilisation comme marqueur de selection par exemple pour controler le transfert d'acides nucleiques.
NO972063L (no) Isolert BMP-reseptorkinaseprotein, DNA-sekvens, rekombinant ekspresjonsvektor samt vertscelle
EP0374503A3 (en) Improvements in and relating to the regulation of gene expression
MD20000034A (ro) Proteinele virusului răsucirii frunzelor de viţă de vie (tipul 2) şi utilizarea lor
ATE316138T1 (de) Rekombinante expression von s-layer-proteinen
Roberts et al. Different active sites of mammalian DNA ligases I and II.
FI951633A (fi) Erittyvien proteiinien lisääntynyt tuotanto eukaryoottisilla yhdistelmäsoluilla
ATE346919T1 (de) Nebenhoden-spezifisches rezeptorprotein und dessen verwendung
BR9508430A (pt) Sequência nucleotídica ADN recombinante vetor de expressão com replicação autônoma e/ou integrativo célula recombinante polipeptideo processo de produção de um polipeptideo topoismorase isolada e utilização de uma topoisomeras IV
HUP9801330A2 (hu) Új PKA-kötő fehérjék és alkalmazásuk
ATE247710T1 (de) Genexpression von utrophin
NO178870C (no) Fremgangsmåte for fremstilling av modifisert Eglin B eller C samt DNA, ekspresjonsvektor og vertsmikroorganisme